Skip to navigation Skip to content

Share

Master Page Does Not Exist

    Services

    Master Page Does Not Exist
    1. Pharmaceutical Financial Assistance Programs

      A list of pharmaceutical and non profit financial assistance programs to assist with the costs of MS medications.

    Resources

    Master Page Does Not Exist
    1. Lending Library

      The Midwest Regional Lending Library provides free access to accurate, current, and comprehensive information to people with MS, those who care for them, and health professionals through the Midwest Regional Lending Library. Books, DVDs, and CDs are available on a variety of topics including symptom management, emotional health, exercise, family support, disease information, and more.

    2. Research Directions in MS: Strategies and Progress (.pdf)

      Explains the Society’s comprehensive research approaches to stopping MS in its tracks, restoring what’s been lost, and ending MS forever. For nonscientists.

    3. Initiating and Adhering to Treatment with Injectable Disease Modifying Agents (.pdf)

      To date, there are six disease-modifying agents that have been approved for the treatment of MS. The National MS Society recommends...

    4. Clinical Bulletin - Physical Therapy in MS Rehabilitation (.pdf)

      Rehabilitation is an important part of health care delivery for persons with MS. Since the majority of people are diagnosed between the ages of 20 and 50, the challenges of MS affect those at the peak of their career and childrearing years.

    5. Clinical Bulletin - Spasticity (.pdf)

      Spasticity is one of the most common symptoms of MS. It can be defined as a velocity-dependent increase in muscle tone, which is usually associated with hyperactive deep tendon reflexes.

    6. Palliative Care (.pdf)

      For healthcare providers, this booklet provides an overview of palliative care.

    7. FDA approves first treatment for primary progressive MS

      New medication Ocrevus also shows benefits in relapsing forms of MS.

    8. Symptomatic Treatment Trials

      This document outlines Symptomatic Treatment Trials.

    9. Multiple Sclerosis and Smoking

      To date, few modifiable risk factors have been found to influence the development or course of MS. Cigarette smoking – which can cause serious health issues including lung cancer, increased risk of infections, and heart disease, and is the primary cause of preventable death in the United States – has also been identified as a risk factor in the development and progression of MS.

    10. MS in the Workplace: A Guide for Employers (video)

      This video is a resource for employers, featuring discussions about multiple sclerosis in the workplace.

    11. Depression In MS

    12. MS News (video)

      This video features Richard Rudick, MD, who discusses Ampyra, Tysabri, and stem cell research.

    13. Review of Regular Medications and Supplements (.pdf)

      A form to help people keep track of their prescription drugs, over-the-counter remedies, herbals, vitamins, or other dietary supplements.

    14. Promising MS Research - Recorded Webcast

      Promising MS Research to Repair, Protect and Restore the Nervous System. Moderator Kate Milliken and panelists Dr. Ben Barres, Dr. Jonah Chan, Dr. Timothy Coetzee and Dr. Rhonda Voskuhl. December 5, 2013

    15. National MS Society's Research Program (video)

      This video features a discussion with Richard Rudick, MD, who discusses the multiple sclerosis research programs funded by the National MS Society.

    16. MS Navigator (.pdf)

      Finding answers and making sound decisions relies on having the right information at the right time. That’s what the National MS Society provides — answers to your questions and access to information about the options available to you.

    17. MS for the Physician Assistant: A Practical Primer (.pdf)

      This book is a practical starting guide for physician assistants who work with MS patients.

    18. Trials-Funded-by-National-MS-Society (.pdf)

      Trials funded by the National MS Society as of September 2013.

    19. Fast Forward and Myelin Repair Foundation (Start Up, Apr. 2012) (.pdf)

      Despite the availability of new oral medicines, broader advances in MS remains farther away, especially for patients with advanced MS. Two nonprofit group are thinking creatively to make those breakthroughs come sooner.

    20. From Clinical Trials to Treatments

      This presentation is: From Clinical Trials to Treatments.

    21. Clinical Trials in MS

      Large Phase 3 trials in RR MS. Updated September 2013. Abbreviations Key: AAN – American Academy of Neurology. CIS – Clinically Isolated Syndrome.

    22. Instructions for Online Submission of Research Grant Applications (.pdf)

      Instructions for Submission: Research Grant Applications National MS Society

    23. Summary Evaluation Charts (.pdf)

      This document provides an assessment of the National MS Society's operations and research portfolio.

    24. How We Will Stop MS (.pdf)

      This document explores how potential MS therapies in development (and newly in existence) are changing the treatment of MS.

    25. Clinical Fellowship Program (.pdf)

      The document explains the MS Clinical Care Physician Fellowship, including information about eligibility and evaluations.

    26. Applying for Pilot Research Grants (.pdf)

      The National MS Society provides funds for limited short-term support of research in areas where preliminary data are scant or nonexistent. This program is designed to support unique or novel ideas with the potential to open significant new areas of research on MS.

    27. Rehabilitation: Recommendations for Persons with MS (.pdf)

      The Medical Advisory Board of the National MS Society has adopted the following recommendations to provide guidance to physicians, nurses, therapists, insurers, and policy makers, regarding the appropriate use of rehabilitative therapies in MS.

    28. Timeline of MS Research (.pdf)

      This timeline highlights a selection of major landmarks in research into MS and the launch of programs to propel this research forward.

    29. Applying for Society-ABF MS Clinician Scientist Development Award (.pdf)

      The National MS Society and American Brain Foundation have committed to support the training of outstanding residency-level clinicians in MS clinical research through the National MS Society-ABF MS Clinician-Scientist Development Award.

    30. Applying for Postdoctoral Fellowships (.pdf)

      The National MS Society welcomes applications for support of training of postdoctoral fellows in studies related to MS which may serve to advance the mission of the Society.

    31. Applying for Research Grants (.pdf)

      The National MS Society welcomes applications for support of studies related to MS which may serve in any way to advance the mission of the Society.

    32. Applying for Mentor-Based Postdoctoral Fellowship In Rehabilitation Research (.pdf)

      The National MS Society welcomes applications for support of mentors and institutions that provide training of postdoctoral fellows in research related to MS rehabilitation which may serve to advance the mission of the Society.

    33. Applying for Collaborative MS Research Centers (.pdf)

      The National MS Society welcomes applications for support of Collaborative MS Research Centers which will help stimulate collaboration and interaction in MS research among independent investigators, strengthen the ties between basic and clinical research, and stimulate recruitment of researchers from other fields into MS research.

    34. Applying for Sylvia Lawry Physician Fellowships (.pdf)

      It is the intent of this program that the individual with an MD or equivalent medical degree will acquire formal training in a broad range of key elements associated with conducting clinical trials in MS.

    35. Policies and Procedures: Research Funding Programs and Other Awards (.pdf)

      The National MS Society is empowered to make grants of money for use by individuals within lawfully established agencies or institutions to further its mission.

    36. Poor Vision (.pdf)

      This clinical bulletin for health professionals explores how MS patients may experience vision problems and explains common diagnoses.

    37. Vitamin D and MS: Implications for Clinical Practice (.pdf)

      This clinical bulletin for health professionals explores how recent studies have changed our understanding of the effects of vitamin D on the body and human health.

    38. Request for Applications on Risk Factors for MS Progression (.pdf)

      This announcement from the National MS Society introduces a 2010 research initiative to develop and pilot test innovative methodology to test risk factors that predict, and correlate with, disease progression in MS.

    39. MS CDMRP Funding (.pdf)

      This position statement paper, produced by the National MS Society, asks Congress to appropriate $10 million in 2014 for the Multiple Sclerosis Congressionally Directed Medical Research Program.

    40. Nervous System Repair and Protection Initiative (.pdf)

      This paper explores the promises the National MS Society has made and how those promises have blossomed into functional results.

    41. Society Response to Evaluation (.pdf)

      Learn about the National MS Society's view regarding Philanthropy Advisory Service's philosophy regarding intellectual property.

    42. FasterCures Philanthropy Advisory Service (.pdf)

      This is the National Multiple Sclerosis Society Organizational Report from May 2010.

    43. Reproductive Issues in Persons with MS (.pdf)

      This clinical bulletin for health professionals explores reproductive issues in people with MS.

    44. How We Will End MS (.pdf)

      This document reviews how the National MS Society aggressively pursues studies to identify all common MS-related genes and continue fighting toward ending MS.

    45. How We Will Restore Function (.pdf)

      This document explores how the National MS Society is working to further research and create strategies to repair the nervous system and restore function to people with MS.

    46. Tecfidera Appeal Letter & Abstracts (.pdf)

      This document includes a letter of appeal for MS patients who may have been denied coverage, as well as supporting facts and information.

    47. Lyrica Appeal Letter & Abstract (.pdf)

      This document includes a form letter for MS patients who may have been denied coverage of Lyrica, as well as supporting abstracts.

    48. Gilenya Appeal Letter & Abstract (.pdf)

      This document includes a form letter for MS patients who may have been denied coverage of Gilenya, as well as supporting abstracts.

    49. Ampyra Appeal Letter & Abstracts

      This document includes a form letter for MS patients who may have been denied coverage of Ampyra, as well as supporting abstracts.

    50. TipSheet: 2010 Revisions to the McDonald Criteria for the Diagnosis of MS (.pdf)

      This document provides the 2010 revised McDonald diagnostic criteria for MS.

    51. 2010 Fellowships (.pdf)

      This document outlines 2010 clinical fellowships and describes each one.

    52. Advisory Committee for Biomedical Research Committee B (pdf)

      Advisory Committee ‘B’ for Biomedical Research: 2013 Members List

    53. Advisory Committee for Biomedical Research Committee D (.pdf)

      Advisory Committee ‘D’ for Biomedical Research - 2013 Members List

    54. Nurse's Quick Reference (.pdf)

      The Nurse’s quick reference serves as a guide for nurses caring for patients with MS.

    55. Advisory Committee for Pilot Glial/Myelin Research (.pdf)

      National MS Society Scientific Peer Review Committee for Pilot Research Awards: Glial/Myelin Biology - Member List

    56. Advisory Committee for Pilot Immunity Research (.pdf)

      National MS Society Scientific Peer Review Committee for Pilot Research Awards: Immunology - Member List

    57. Society Research Efforts in Progressive MS (.pdf)

      Progressive MS is a focus of the National MS Society’s Strategic Response to MS. MS progression can be slow or it can be fast, but it occurs in many of those who have the disease, even in people successfully treated for relapses.

    58. Health Care Reform Principles (.pdf)

      America’s health care crisis prevents many people with MS from living as powerfully as they could. In response, the National MS Society is relentlessly working to shape the health policies of tomorrow.

    59. Special Focus on Rehabilitation (MS Professional Connection, June 2012) (.pdf)

      The focus is on rehabilitation and on some exciting new findings related to vestibular rehabilitation, walking and exercise training that reinforce the benefits of rehab for people living with MS.

    60. Document-Adherence to Therapy (MS Professional Connection, Fall 2012)

      Many factors have been associated with poor adherence to disease-modifying therapy in MS.

    61. Classification of Acquired Inflammatory CNS Demyelination in Children (.pdf)

      Chart shows First Attack of Demyelination and Further Demyelinating Attacks

    62. Prototypical MRI Findings in MS (.pdf)

      MRI findings (images)

    63. Opinion Paper-Rehabilitation (2004) (.pdf)

      The Medical Advisory Board of the National MS Society has adopted the following recommendations to provide guidance to physicians, nurses, therapists, insurers, and policy makers, regarding the appropriate use of rehabilitative therapies in MS. This document addresses physical rehabilitation.

    64. Cavallo Treatment Update (.pdf)

      Since 1993 the U.S. FDA has approved several medications for use in MS. For the first time, we have the ability to reduce disease activity for many people with MS.

    65. January 2013 New Website Supports Your MS Practice (.pdf)

      The National MS Society looks forward to partnering with you to promote optimal MS care through our new MS Clinical Care Network, a gateway to a variety of innovative resources to support your practice.

    66. Research-America MS Fact Sheet (.pdf)

      This fact sheet explores MS, research and hopes for the future.

    67. April 2013 Focus on Cognition (.pdf)

      This clinical document explores how Multiple Sclerosis and cognitive impairment may be related, and the current treatments and research that are occurring.

    68. Physician's Guide to Mobility Options & Prescription Documentation (.pdf)

      This guide for physicians explores customized wheeled mobility options for MS patients, and explains what prescription documentation may be needed.

    69. Aubagio Appeal Letter & Abstracts (.pdf)

      A request for re-consideration of denial/limitation of coverage for Aubagio for patients.

    70. Focus on Disease-Modifying Therapies (MS Professional Connection, July 2013) (.pdf)

      As new treatments emerge for the management of MS, physicians and patients are facing challenging discussions about risk, benefits and other factors to collaboratively determine the best course for any given patient.

    71. Institutional Clinician Training Award Program Guidelines and Instructions (.pdf)

      Consistent with its mission to move toward a world free of MS, the National MS Society supports the professional development and training of physicians in the comprehensive care of people with MS.

    72. Society-issued Letter to 60 Minutes (.pdf)

      Society-issued letter to 60 Minutes regarding a misleading broadcast.

    73. Breaking Research News (MS Professional Connection, Oct. 2013) (.pdf)

      With 10 MS disease-modifying agents currently available, new options expected within the next few months and several more in the research pipeline, treatment decisions are becoming increasingly complex.

    74. Application Checklist for Health Insurance Marketplace (.pdf)

      Application checklist for health insurance marketplace

    75. Introduction: Funding Policy Overview (.pdf)

      This is an introduction to the National MS Society's funding policies.

    76. Sample Psychologist-to-SSA Letter (.pdf)

      This sample letter is designed as a guide to help you draft a personalized medical report documenting mental impairment.

    77. Clinical Bulletin - Swallowing Disorders and Their Management (.pdf)

      Permanent and transitory swallowing disorders occur in patients with MS. In fact, swallowing disorders may be present long before the person with MS experiences any related symptoms.

    78. Management of MS-Related Fatigue (.pdf)

    79. Advisory Committee on Fellowship (.pdf)

      Advisory Committee on Fellowship: 2013 Membership

    80. Joint Conference on Primary-Progressive MS Focuses on Unmet Needs (.pdf)

      Distinct differences and specific needs characterize people living with primary progressive MS. The Society and the MS Association of America are striving to meet more of these needs by working together.

    81. Current Research Projects Funded by the NMSS

      List of Current Research Projects Funded by the National MS Society

    82. Research Programs Advisory Committee (.pdf)

      2013-2014 National MS Society Research Programs Advisory Committee

    83. Advisory Committee on Health Care Delivery and Policy Research (.pdf)

      Advisory Committee on Health Care Delivery and Policy Research: 2013 Members List

    84. Advisory Committee for Research on Patient Care, Management and Rehabilitation (.pdf)

      Scientific Peer Review Committee C: 2013 Members Listing

    85. Advisory Committee for Biomedical Research Committee A (pdf)

      Advisory Committee ‘A’ for Biomedical Research: 2013 Members List

    86. Health Care Delivery and Policy Research Projects (.pdf)

      The Society offers multi-year contracts to health services investigators. Projects will be supported that address current priorities in the organization, funding, quality, outcomes, and costs of MS care

    87. Applying for Harry Weaver Neuroscience Scholar Awards (.pdf)

      A limited number of awards will be offered to highly qualified candidates who have concluded their research training and begun academic careers as independent investigators in an area related to MS.

    88. Career Transition Fellowship (.pdf)

      The National MS Society has determined that ending the devastating effects of MS will require a cadre of well-trained scientists engaged in MS-related research. The Society’s Career Transition Fellowship addresses this need by fostering the development and productivity of young scientists who have potential to make significant contributions to MS research and help ensure the future and stability of MS research.

    89. Pain (.pdf)

      This clinical bulletin for health professionals explores how pain - a common MS sympton - impacts MS patients.

    90. Sylvia Lawry Patient Database (.pdf)

      Since 2001, the Sylvia Lawry Centre for MS Research has been building the world’s largest database of patient information. With this invaluable tool, we hope to enable researchers to plot the way this mysterious disease develops in patients and find effective ways of treating it.

    91. Our Strategic Response (.pdf)

      This white paper reflects key information gathered from all audiences and was used to inform the development of the National MS Society's Strategic Response for 2011-2015.

    92. Strategic Response to MS (.pdf)

      This brochure outlines the National MS Society's goals as an organization.

    93. Diagnostic Workup for Patients with Suspected Demyelinating Disease - Testing Options (.pdf)

      Diagnostic Workup for Patients with Suspected Demyelinating Disease - Testing Options

    94. National MS Society Fact Sheet (.pdf)

      This fact sheet explains about Multiple Sclerosis and the National Multiple Sclerosis Society.

    95. Twins and MS (video)

      This video features Mary Hughes, MD, who answers a viewer's question about why she got multiple sclerosis but not her twin.

Share

Master Page Does Not Exist
© 2024 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.